Designation for BXCL701 in combination with a checkpoint inhibitor (CPI) for treatment of patients with metastatic SCNC with progression on chemotherapy and no evidence...
insitro, a machine learning-powered drug discovery and development company, announced the appointment of S. Michael Rothenberg, M.D., Ph.D., as chief medical officer. In this...